Huntleigh Advisors, Inc. Kamada LTD Transaction History
Huntleigh Advisors, Inc.
- $518 Billion
- Q2 2025
A detailed history of Huntleigh Advisors, Inc. transactions in Kamada LTD stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 135,776 shares of KMDA stock, worth $966,725. This represents 0.2% of its overall portfolio holdings.
Number of Shares
135,776
Previous 130,625
3.94%
Holding current value
$966,725
Previous $863 Million
21.87%
% of portfolio
0.2%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding KMDA
# of Institutions
42Shares Held
5.43MCall Options Held
14.3KPut Options Held
2K-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.8 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny808KShares$5.76 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA609KShares$4.33 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny448KShares$3.19 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3330KShares$2.35 Million0.19% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $319M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...